| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings
|
Cecchi, Marco
|
|
2015
|
|
4 |
p. 387-394
8 p.
|
artikel
|
| 2 |
Alzheimer's genetic risk intensifies neurocognitive slowing associated with diabetes in nondemented older adults
|
McFall, G. Peggy
|
|
2015
|
|
4 |
p. 395-402
8 p.
|
artikel
|
| 3 |
A priori collaboration in population imaging: The Uniform Neuro-Imaging of Virchow-Robin Spaces Enlargement consortium
|
Adams, Hieab H.H.
|
|
2015
|
|
4 |
p. 513-520
8 p.
|
artikel
|
| 4 |
Cerebral atrophy in mild cognitive impairment: A systematic review with meta-analysis
|
Tabatabaei-Jafari, Hossein
|
|
2015
|
|
4 |
p. 487-504
18 p.
|
artikel
|
| 5 |
Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
|
Forlenza, Orestes V.
|
|
2015
|
|
4 |
p. 455-463
9 p.
|
artikel
|
| 6 |
Computer mouse movement patterns: A potential marker of mild cognitive impairment
|
Seelye, Adriana
|
|
2015
|
|
4 |
p. 472-480
9 p.
|
artikel
|
| 7 |
Development of a subjective cognitive decline questionnaire using item response theory: A pilot study
|
Gifford, Katherine A.
|
|
2015
|
|
4 |
p. 429-439
11 p.
|
artikel
|
| 8 |
Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes
|
Pijnenburg, Yolande A.L.
|
|
2015
|
|
4 |
p. 505-512
8 p.
|
artikel
|
| 9 |
Five-year biomarker progression variability for Alzheimer's disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps?
|
Tarnanas, Ioannis
|
|
2015
|
|
4 |
p. 521-532
12 p.
|
artikel
|
| 10 |
Intracranial arterial four-dimensional flow is associated with metrics of brain health and Alzheimer's disease
|
Berman, Sara E.
|
|
2015
|
|
4 |
p. 420-428
9 p.
|
artikel
|
| 11 |
Letter to the editor regarding: Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective
|
Kamer, Angela R.
|
|
2015
|
|
4 |
p. 385-386
2 p.
|
artikel
|
| 12 |
Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease
|
Doody, Rachelle S.
|
|
2015
|
|
4 |
p. 464-471
8 p.
|
artikel
|
| 13 |
Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study
|
Stomrud, Erik
|
|
2015
|
|
4 |
p. 403-411
9 p.
|
artikel
|
| 14 |
Predicting conversion to dementia in a memory clinic: A standard clinical approach compared with an empirically defined clustering method (latent profile analysis) for mild cognitive impairment subtyping
|
McGuinness, Bernadette
|
|
2015
|
|
4 |
p. 447-454
8 p.
|
artikel
|
| 15 |
Revolutionizing Alzheimer's disease and clinical trials through biomarkers
|
Mattsson, Niklas
|
|
2015
|
|
4 |
p. 412-419
8 p.
|
artikel
|
| 16 |
Semantic and nonfluent aphasic variants, secondarily associated with amyotrophic lateral sclerosis, are predominant frontotemporal lobar degeneration phenotypes in TBK1 carriers
|
Caroppo, Paola
|
|
2015
|
|
4 |
p. 481-486
6 p.
|
artikel
|
| 17 |
Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes
|
Weston, Philip S.J.
|
|
2015
|
|
4 |
p. 440-446
7 p.
|
artikel
|
Tijdschrift beschrijving